Komori
Share Issuance and Disposal4894Cuorips Inc.Pharmaceuticals

Supplementary Materials on the Issuance of New Shares Through a Third-Party Allotment and the Issuance of the First Unsecured Straight Bonds

The company plans to raise a total of ¥4 billion by combining ¥3 billion from the private placement of new shares with ¥1 billion from unsecured straight corporate bonds. The funds will be used for research and development of second-generation cardiac muscle cell sheets, catheter-based treatment, agents that induce endogenous regenerative factors, and mesenchymal stem cells.

Worth reading
—
Scored from 0 of 3 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
40
Hundreds of millions of yen
Wording
Definitive
How definitive the wording is.

What was corrected and how

A subsequent correction by the company to the contents of an already published filing.

Original disclosure
The number of days elapsed cannot be calculated because the original disclosure date is unknown.
This correction2026-09-11
What was corrected and how
ItemDetails
Items this document does not state (6)
Disclosure subject to correctionOriginal disclosure dateLocation of correctionDetails of correctionReason for correctionImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To accelerate research and development of next-generation pipeline products following ReHeart® and strengthen the financial base by increasing available liquidity. Common shares and straight corporate bonds were combined to limit dilution for existing shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Materials on the Issuance of New Shares Through a Third-Party Allotment and the Issuance of the First Unsecured Straight Bonds | Cuorips Inc. (4894) timely disclosure | Komori